Cdt2 Antibodies

Santa Cruz Biotechnology features a diverse variety of Cdt2 monoclonal antibodies for research in cell cycle regulation and DNA damage response. Cdt2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdt2, a crucial regulator of the cell cycle, plays a significant role in the degradation of proteins involved in DNA replication and repair. By mediating the ubiquitination of target proteins, Cdt2 ensures proper cell cycle progression and maintains genomic stability. Understanding Cdt2 function is essential for elucidating mechanisms of cancer development and progression. Cdt2 monoclonal antibodies enable researchers to explore cellular pathways and molecular mechanisms involved in DNA damage response. Investigating Cdt2's role in cell cycle regulation provides insights into potential therapeutic targets for cancer treatment. Research with Cdt2 monoclonal antibodies helps uncover new aspects of DNA replication and repair mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cell cycle regulation and its impact on human health.